BAKAR ATEŞ, F. 2016. Cucurbitacin B Enhances the Anticancer Effect of Imatinib Mesylate Through Inhibition of MMP-2 Expression in MCF-7 and SW480 Tumor Cell Lines. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.16, no.6 , 747-754.

BAKAR ATEŞ, F., (2016). Cucurbitacin B Enhances the Anticancer Effect of Imatinib Mesylate Through Inhibition of MMP-2 Expression in MCF-7 and SW480 Tumor Cell Lines. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.16, no.6, 747-754.

BAKAR ATEŞ, FİLİZ. "Cucurbitacin B Enhances the Anticancer Effect of Imatinib Mesylate Through Inhibition of MMP-2 Expression in MCF-7 and SW480 Tumor Cell Lines," ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.16, no.6, 747-754, 2016

BAKAR ATEŞ, FİLİZ B. . "Cucurbitacin B Enhances the Anticancer Effect of Imatinib Mesylate Through Inhibition of MMP-2 Expression in MCF-7 and SW480 Tumor Cell Lines." ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.16, no.6, pp.747-754, 2016

BAKAR ATEŞ, F. (2016) . "Cucurbitacin B Enhances the Anticancer Effect of Imatinib Mesylate Through Inhibition of MMP-2 Expression in MCF-7 and SW480 Tumor Cell Lines." ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.16, no.6, pp.747-754.

@article{article, author={FİLİZ BAKAR ATEŞ}, title={Cucurbitacin B Enhances the Anticancer Effect of Imatinib Mesylate Through Inhibition of MMP-2 Expression in MCF-7 and SW480 Tumor Cell Lines}, journal={ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY}, year=2016, pages={747-754} }